HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
Yuriko LimmadeLiony FransiscaRodrigo Rodriguez-FernandezMichael J BangsCamilla RothePublished in: PloS one (2019)
Virological response at six months after beginning ART is the strongest predictor of viral suppression at 12 and 36 months, and may help in identifying patients needing additional adherence therapy support. Higher baseline CD4 positively affects the immunological outcomes of patients. The findings indicate HIV control programs should prioritize the availability of VL testing and begin ART regardless of CD4 counts in infected patients.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- end stage renal disease
- hiv aids
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- public health
- type diabetes
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- weight loss
- smoking cessation